Next Harm Reduction Inc
Analysis
Next Harm Reduction Inc is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in February 2020, 6 years ago. Its declared purposes cover mental health and crisis intervention, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Next Harm Reduction Inc reported income of $2.0m and spending of $1.8m, spending 89% of its income. Across the 4 years on record, from June 2020 to June 2023, income grew from $557k to $2.0m (+262%), an average of +54% a year. The sharpest change came in the year to June 2022, when income rose by 144%. Over the whole period it spent 84% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Next Harm Reduction Inc sits at the 72nd percentile: it is larger than about 72% of them. Against every charity in United States with reported income it ranks in the 86th percentile, and in the 83rd percentile within NY. Charities of a similar size with the same main cause include Interim House Inc ($2.0m), Redlands Community Hospital Foundation ($2.0m) and East Ky Health Service Center ($2.0m).
On its Form 990 for the period ending June 2023, revenue came from contributions and grants 100% of the total. Other salaries and wages came to $444k. At year end it held assets of $1.3m against liabilities of $377k, net assets of $887k. It reported 11 employees.
Income and spending
Where the income comes from
- Contributions & grants 100%
- Other 0.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Interim House Inc | Philadelphia | $2.0m |
| Redlands Community Hospital Foundation | Redlands | $2.0m |
| East Ky Health Service Center | Hindman | $2.0m |
| Childrens Hospital at Sinai Foundation Inc | Baltimore | $2.0m |